Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImmunoStat: LILRB5 Genotype Impact on Atorvastatin
NCT02984293Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Apr 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in hypercholesterolemia, sponsored by University of Dundee. Started Apr 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02984293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984293.